These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36507985)

  • 21. Study of Vesicular Monoamine Transporter 2 in Myopic Retina Using [
    Sun Y; Zhao N; Liu W; Liu M; Ju Z; Li J; Cheng Z; Liu X
    Mol Imaging Biol; 2018 Oct; 20(5):771-779. PubMed ID: 29520623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separating dopamine D
    Smart K; Gallezot JD; Nabulsi N; Labaree D; Zheng MQ; Huang Y; Carson RE; Hillmer AT; Worhunsky PD
    Neuroimage; 2020 Jul; 214():116762. PubMed ID: 32201327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas.
    Fagerholm V; Mikkola KK; Ishizu T; Arponen E; Kauhanen S; Någren K; Solin O; Nuutila P; Haaparanta M
    J Nucl Med; 2010 Sep; 51(9):1439-46. PubMed ID: 20720057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [
    Slifstein M; Abi-Dargham A; Girgis RR; Suckow RF; Cooper TB; Divgi CR; Sokoloff P; Leriche L; Carberry P; Oya S; Joseph SK; Guiraud M; Montagne A; Brunner V; Gaudoux F; Tonner F
    Psychopharmacology (Berl); 2020 Feb; 237(2):519-527. PubMed ID: 31773210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of the preferential D
    Petragnano F; Fasciani I; Mannoury la Cour C; di Cara B; Aloisi G; Carli M; Kolachalam S; Rossi M; Marampon F; Scarselli M; Millan MJ; Maggio R
    Eur J Pharmacol; 2022 Jun; 925():175016. PubMed ID: 35545150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
    Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
    Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models.
    Schäfer MK; Hartwig NR; Kalmbach N; Klietz M; Anlauf M; Eiden LE; Weihe E
    Diabetologia; 2013 May; 56(5):1047-56. PubMed ID: 23404442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
    Freeby M; Goland R; Ichise M; Maffei A; Leibel R; Harris P
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():98-108. PubMed ID: 18834437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET Imaging of VMAT2 with the Novel Radioligand [
    Nag S; Jahan M; Tóth M; Nakao R; Varrone A; Halldin C
    ACS Chem Neurosci; 2021 Dec; 12(24):4580-4586. PubMed ID: 34813272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.
    Gallezot JD; Zheng MQ; Lim K; Lin SF; Labaree D; Matuskey D; Huang Y; Ding YS; Carson RE; Malison RT
    J Nucl Med; 2014 Jun; 55(6):960-6. PubMed ID: 24732151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ¹²⁴I-Epidepride: a PET radiotracer for extended imaging of dopamine D2/D3 receptors.
    Pandey S; Venugopal A; Kant R; Coleman R; Mukherjee J
    Nucl Med Biol; 2014; 41(5):426-31. PubMed ID: 24602412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [
    Schneier FR; Slifstein M; Whitton AE; Pizzagalli DA; Reinen J; McGrath PJ; Iosifescu DV; Abi-Dargham A
    Biol Psychiatry; 2018 Oct; 84(8):563-573. PubMed ID: 30041971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice.
    Rabiner EA; Slifstein M; Nobrega J; Plisson C; Huiban M; Raymond R; Diwan M; Wilson AA; McCormick P; Gentile G; Gunn RN; Laruelle MA
    Synapse; 2009 Sep; 63(9):782-93. PubMed ID: 19489048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.
    Goland R; Freeby M; Parsey R; Saisho Y; Kumar D; Simpson N; Hirsch J; Prince M; Maffei A; Mann JJ; Butler PC; Van Heertum R; Leibel RL; Ichise M; Harris PE
    J Nucl Med; 2009 Mar; 50(3):382-9. PubMed ID: 19223416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [
    Zhao C; Liu C; Tang J; Xu Y; Xie M; Chen Z
    Mol Imaging Biol; 2020 Apr; 22(2):265-273. PubMed ID: 31165386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease.
    Chen MK; Kuwabara H; Zhou Y; Adams RJ; Brasić JR; McGlothan JL; Verina T; Burton NC; Alexander M; Kumar A; Wong DF; Guilarte TR
    J Neurochem; 2008 Apr; 105(1):78-90. PubMed ID: 17988241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas.
    Freeby M; Ichise M; Harris PE
    Islets; 2012; 4(6):393-7. PubMed ID: 23221614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of anesthetics on vesicular monoamine transporter type 2 binding to ¹⁸F-FP-(+)-DTBZ: a biodistribution study in rat brain.
    Chen Z; Tang J; Liu C; Li X; Huang H; Xu X; Yu H
    Nucl Med Biol; 2016 Jan; 43(1):124-129. PubMed ID: 26526872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats.
    Tsao HH; Lin KJ; Juang JH; Skovronsky DM; Yen TC; Wey SP; Kung MP
    Nucl Med Biol; 2010 May; 37(4):413-9. PubMed ID: 20447551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.